Category: Pharmaceutical Stocks

F&O in the press – Unilever bids £50bn for GSK assets

By

Today’s Proactive Investors website reports on Unilever’s £50bn bid for GlaxoSmithKline’s consumer healthcare business. Unilever reportedly made three unsolicited approaches for the business. The offer fails to include a significant premium, often required to convince firms to part with their assets. GlaxoSmithKline said the bids fundamentally undervalue the business. “GSK is thought to be holding … Continued